Orchid Pharma P/B Ratio

Current P/B Ratio
3.81
High Valuation
High - Premium to book value, growth expectations or asset-light model

Orchid Pharma P/B ratio. Orchid Pharma (ORCHPHARMA) P/B ratio is 3.81 (High), book value per share ₹260.67 vs Healthcare average P/B of 0.01 — High - Premium to book value, growth expectations or asset-light model. View ORCHPHARMA price range for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio 3.81
Current Price ₹965.90
Book Value/Share ₹260.67
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹1,564 Cr
Share Capital ₹60 Cr
Reserves & Surplus ₹1,504 Cr
Outstanding Shares 60,000,000
Book Value per Share ₹260.67

Valuation Signal

Signal Overvalued
Historical Avg 4.21
Historical Range 2.31 - 7.88
Percentile 60.0%

Sector Context

Sector Average 0.01
Sector Median 0.65
Sector Rank #11 of 50
Sector Percentile 22.0%

ORCHPHARMA P/B Ratio — Valuation Insights & Book Value Analysis

Orchid Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 3.81 (High). For live price, earnings yield and the full fundamental profile, see Orchid Pharma screener.

  • Stock appears overvalued with PB of 3.81, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Trading at premium to sector average PB of 0.01

Orchid Pharma P/B Ratio Historical Trend

ORCHPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse ORCHPHARMA shareholding pattern to track promoter, FII and institutional holdings.

ORCHPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price

Orchid Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 3.71 ₹260.67 ₹965.90 ₹1,564 High
2025 2.93 ₹259.0 ₹758.95 ₹1,554 Moderate
2024 7.88 ₹229.41 ₹1807.05 ₹1,170 High
2023 4.24 ₹168.05 ₹712.50 ₹689 High
2022 2.31 ₹157.8 ₹364.05 ₹647 Moderate

ORCHPHARMA vs Healthcare Peers — P/B Ratio Comparison

Orchid Pharma P/B 3.81 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.

Sector Average
0.01
Sector Median
0.65
Lowest P/B
-6.55
Highest P/B
1.13
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹35 Low
Krebs Biochemicals & Ind… KREBSBIO -0.8 ₹147 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹47 Low
Triochem Products TRIPR 0.04 ₹0 Low